by Ian Harvey
July 28, 2018
OUT WHILST THE GOING IS GOOD!
GREED CAN BE THE UNDOING OF A GOOD PROFIT!
Eli Lilly and Co. (NYSE:LLY)
Here is an update of Eli Lilly and Co. (NYSE:LLY) options trade. This options trade was recommended to “Cut-to-the-Chase” Members on Thursday, July 12, 2018, based on J.P. Morgan Securities seeing optimism on the company's early product launch cycles plus earnings expectations; providing a potential profit of 642%!
PATIENCE PAYS OFF!
YOU NEED TO BE IN TO PROFIT!
…….from…… “Cut-to-the-Chase” Recommendations
Drug manufacturer Eli Lilly and Co. (NYSE:LLY) was named as a top pick among pharma stocks by J.P. Morgan Securities; and seeing optimism on the company's early product launch cycles.
Eli Lilly and Company is expected to report earnings on July 24, 2018 before the market opens. The report will be for the fiscal Quarter ending Jun 2018. Based on 5 analysts' forecasts, the consensus EPS forecast for the quarter is $1.34. The reported EPS for the same quarter last year was $1.11.
Eli Lilly last posted its quarterly earnings data on Tuesday, April 24th. The company reported $1.34 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.13 by $0.21. Eli Lilly had a return on equity of 35.37% and a net margin of 4.82%. The company had revenue of $5.70 billion for the quarter, compared to analysts’ expectations of $5.51 billion. During the same period in the previous year, the firm posted $0.98 EPS. Eli Lilly revenue was up 9.0% compared to the same quarter last year. Equities analysts forecast that Eli Lilly And Co will post 5.15 EPS for the current fiscal year.
Over the past 7 days, Eli Lilly stock has increased in price by 2.55%. Looking backwards over the past quarter, these shares have gained 11.15%. Turning to look at the last 6 months, this stock has added 2.23% to its price. Since the beginning of the calendar year, this stock has moved up by 7.01%.
Option trade to consider: Buy the LLY AUG 20 2018 90.000 CALL at approximately $0.95.
Eli Lilly and Co. made steady upward movement since the execution of the options trade. But the earnings report on Tuesday managed to send the stock upwards providing plenty of extra profit on this options trade. Is it time to exit the trade with such great profits ….. read this….
Lilly beat estimates for both earnings and sales and also raised its outlook for 2018 for the second time this year. While Lilly’s earnings per share rose 35% year over year, sales increased 9% in the quarter.
Eli Lilly Chief Executive David Ricks described the quarter’s revenue increases as“fueled by volume growth of our new medicines, while we also maintained a keen focus on containing costs and improving productivity.”
Lilly announced that the strategic review of its Elanco Animal Health unit is now complete. It has been decided that it will establish Elanco as an independent publicly traded company via an initial public offering (IPO) and subsequent separation. Lilly said it will initially pursue an IPO of a minority stake of less than 20% in the separated Elanco unit.
As well, Lilly also said it would not increase its drug prices through the end of the year, as the Trump Administration pushes to cut costs for patients.
The company also announced a $8 billion share buyback program.
Shares of the company rose as much as 2.6 percent to touch a near three-year high of $91.20.
So, for “Cut-to-the-Chase” members who managed to execute this trade recommended by Stock Options Made Easy; a potential profit of more than 642% -- time to EXIT?
Entering the option trade at a cost of $0.95 or less; reaching as high as $7.05 at Friday’s close; one options contract would provide a profit of $610.00; or 642% Potential Profit.ACTION TO TAKE…….
Even though the original reason for this options trade was not based on earnings; it should be noted that some of our trades are based on earnings predictions. This is not to say all trades recommended to members follow this pattern, but as seen in this scenario, the earnings report was part of the success of the options trade; and during earnings season this strategy has been very profitable.
Sometimes it is our approach to predict whether a company will beat or miss estimates, whether the stock will appreciate or depreciate as a result and what strategies investors and traders can use – such as found with the “Earnings Predictions Program”. This type of prediction is based on thorough investigation and fundamentally based research, and the results have been very exceptional.Strategies to Consider……
"When To Exit A Trade Based On Earnings?".....READ MORE.....
"Trading Capital Management" is a key component of your trading strategy. The strategy, on which we base our trades to achieve maximum profit, and to minimize loss, is contingent on using an equal amount of money for each trade.
Our proven track record says it all!!
If you not a member ……… SIGN IN HERE
If you interested in "Earnings Predictions" just click here……
or "Mentorship Program".....click here....